|
1
|
Ferro A, Peleteiro B, Malvezzi M, Bosetti
C, Bertuccio P, Levi F, Negri E, La Vecchia C and Lunet N:
Worldwide trends in gastric cancer mortality (1980–2011), with
predictions to 2015, and incidence by subtype. Eur J Cancer.
50:1330–1344. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Corso S and Giordano S: How can gastric
cancer molecular profiling guide future therapies? Trends Mol Med.
22:534–544. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. Ca Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bakhoum SF and Compton DA: Kinetochores
and disease. Keeping microtubule dynamics in check! Curr Opin Cell
Biol. 24:64–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Duensing A and Duensing S: Centrosomes,
polyploidy and cancer. Adv Exp Med Biol. 676:93–103. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kramer A, Neben K and Ho AD: Centrosome
replication, genomic instability and cancer. Leukemia. 16:767–775.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Obuse C, Yang H, Nozaki N, Goto S, Okazaki
T and Yoda K: Proteomics analysis of the centromere complex from
HeLa interphase cells: UV-damaged DNA binding protein 1 (DDB-1) is
a component of the CEN-complex, while BMI-1 is transiently
co-localized with the centromeric region in interphase. Genes
Cells. 9:105–120. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Izuta H, Ikeno M, Suzuki N, Tomonaga T,
Nozaki N, Obuse C, Kisu Y, Goshima N, Nomura F, Nomura N and Yoda
K: Comprehensive analysis of the ICEN (Interphase Centromere
Complex) components enriched in the CENP-A chromatin of human
cells. Genes to cells. 11:673–684. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hori T, Okada M, Maenaka K and Fukagawa T:
CENP-O class proteins form a stable complex and are required for
proper kinetochore function. Mol Biol Cell. 19:843–854. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Denais CM, Gilbert RM, Isermann P,
McGregor AL, te Lindert M, Weigelin B, Davidson PM, Friedl P, Wolf
K and Lammerding J: Nuclear envelope rupture and repair during
cancer cell migration. Science. 352:353–358. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Orthwein A, Noordermeer SM, Wilson MD,
Landry S, Enchev RI, Sherker A, Munro M, Pinder J, Salsman J,
Dellaire G, et al: A mechanism for the suppression of homologous
recombination in G1 cells. Nature. 528:422–426. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real time quantitative PCR and
the 2(-Delta Delta C(T)). Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Felciano RM, Bavari S, Richards DR,
Billaud JN, Warren T, Panchal R and Kramer A: Predictive systems
biology approach to broad-spectrum, host-directed drug target
discovery in infectious diseases. Pac Symp Biocomput. 17–28.
2013.PubMed/NCBI
|
|
14
|
Krämer A, Green J, Pollard J Jr and
Tugendreich S: Causal analysis approaches in ingenuity pathway
analysis. Bioinformatics. 30:523–530. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
McAinsh AD, Meraldi P, Draviam VM, Toso A
and Sorger PK: The human kinetochore proteins Nnf1R and Mcm21R are
required for accurate chromosome segregation. EMBO J. 25:4033–4049.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gordon DJ, Resio B and Pellman D: Causes
and consequences of aneuploidy in cancer. Nat Rev Genet.
13:189–203. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liao WT, Song LB, Zhang HZ, Zhang X, Zhang
L, Liu WL, Feng Y, Guo BH, Mai HQ, Cao SM, et al: Centromere
protein H is a novel prognostic marker for nasopharyngeal carcinoma
progression and overall patient survival. Clin Cancer Res.
13:508–514. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mi YJ, Gao J, Xie JD, Cao JY, Cui SX, Gao
HJ, Yao SP, Liu T, Zhang YY, Guo CH, et al: Prognostic relevance
and therapeutic implications of centromere protein F expression in
patients with esophageal squamous cell carcinoma. Dis Esophagus.
26:636–643. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kagawa N, Hori T, Hoki Y, Hosoya O,
Tsutsui K, Saga Y, Sado T and Fukagawa T: The CENP-O complex
requirement varies among different cell types. Chromosome Res.
22:293–303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Choi M, Kipps T and Kurzrock R: ATM
Mutations in Cancer: Therapeutic Implications. Mol Cancer Ther.
15:1781–1791. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Karnitz LM and Zou L: Molecular pathways:
Targeting ATR in cancer therapy. Clin Cancer Res. 21:4780–4785.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Stagni V, Manni I, Oropallo V, Mottolese
M, Di Benedetto A, Piaggio G, Falcioni R, Giaccari D, Di Carlo S,
Sperati F, et al: ATM kinase sustains HER2 tumorigenicity in breast
cancer. Nat Commun. 6:68862015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu R, Tang J, Ding C, Liang W, Zhang L,
Chen T, Xiong Y, Dai X, Li W, Xu Y, et al: The depletion of ATM
inhibits colon cancer proliferation and migration via
B56γ2-mediated Chk1/p53/CD44 cascades. Cancer Lett. 390:48–57.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen WT, Ebelt ND, Stracker TH, Xhemalce
B, Van Den Berg CL and Miller KM: ATM regulation of IL-8 links
oxidative stress to cancer cell migration and invasion. Elife.
4:e072702015. View Article : Google Scholar :
|
|
25
|
Ortiz A, Garcia D and Vicente Y:
Prognostic significance of cyclin D1 protein expression and gene
amplification in invasive breast carcinoma. PLoS One.
12:e01880682017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Qie S and Diehl JA: Cyclin D1, cancer
progression, and opportunities in cancer treatment. J Mol Med.
94:1313–1326. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vaites LP, Lian Z, Lee EK, Yin B, DeMicco
A, Bassing CH and Diehl JA: ATM deficiency augments constitutively
nuclear cyclin D1-driven genomic instability and lymphomagenesis.
Oncogene. 33:129–133. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hitomi M, Yang K, Stacey AW and Stacey DW:
Phosphorylation of cyclin D1 regulated by ATM or ATR controls cell
cycle progression. Mol Cell Biol. 28:5478–5493. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li Y and Yang DQ: The ATM Inhibitor
KU-55933 suppresses cell proliferation and induces apoptosis by
blocking Akt in cancer cells with overactivated Akt. Mol Cancer
Ther. 9:113–125. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Meng Q and Xia Y: c-Jun, at the crossroad
of the signaling network. Protein Cell. 2:889–898. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Peluso I, Yarla NS, Ambra R, Pastore G and
Perry G: MAPK signalling pathway in cancers: Olive products as
cancer preventive and therapeutic agents, Semin. Cancer Biol.
56:185–195. 2019. View Article : Google Scholar
|
|
32
|
Lee SA, Dritschilo A and Jung M: Role of
ATM in oxidative stress-mediated c-Jun phosphorylation in response
to ionizing radiation and CdCl2. J Biol Chem. 276:11783–11790.
2001. View Article : Google Scholar : PubMed/NCBI
|
